Search
for
Sort by
Research 661–690 of 1000+
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Human iPS Cell-Derived Cell Aggregates Exhibited Dermal Papilla Cell Properties in in vitro Three-Dimensional Assemblage Mimicking Hair Follicle Structures
- ‘Dr. Google, What Is That on My Skin?’—Internet Searches Related to Skin Problems: Google Trends Data from 2004 to 2019
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study
- Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Bibliometric evaluation of Anais Brasileiros de Dermatologia (2013-2022)
- IL-15 Prolongs Anagen, Stimulates Proliferation, and Suppresses Apoptosis in the Hair Matrix of Human Scalp Hair Follicles
- Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectives
- Factors influencing alopecia areata treatment decisions: A qualitative assessment
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible
- Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management
- Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- The Complexities of Iron Deficiency in Patients After Bariatric Surgery
- Systemic Vasculitis with Severe Cutaneous Manifestation as a Suspected Idiosyncratic Hypersensitivity Reaction to Fenbendazole in a Cat